Fund overview & performance

Asset class

Portfolio solutions

Based on three-year return


Annualized returns

Between % and %

 


Generations

Fund management

Only available for 75/100 guarantee levels

Guarantee level

Series

Clear all filters

CAN Global All Cap Equity 75/100

September 30, 2025

A value-oriented fund seeking global invesetments for long-term growth.

Is this fund right for you?

  • You want your money to grow over a longer term.
  • You want to invest in equities anywhere in the world.
  • You're comfortable with a moderate level of risk.

Risk Rating

Risk Rating: Moderate

How is the fund invested? (as of September 30, 2025)

Asset allocation (%)

Name Percent
US Equity 52.6
International Equity 44.2
Cash and Equivalents 3.3
Other -0.1

Geographic allocation (%)

Name Percent
United States 52.6
Ireland 11.3
France 7.6
Taiwan 4.2
Switzerland 3.6
Canada 3.2
United Kingdom 2.5
Denmark 2.1
China 2.0
Other 10.9

Sector allocation (%)

Name Percent
Technology 27.6
Financial Services 17.7
Healthcare 9.9
Consumer Goods 9.7
Industrial Goods 9.5
Consumer Services 8.1
Industrial Services 3.9
Energy 3.8
Cash and Cash Equivalent 3.3
Other 6.5

Growth of $10,000 (since inception)

Data not available based on date of inception

Fund details (as of September 30, 2025)

Top holdings %
Alphabet Inc Cl A 4.6
Microsoft Corp 4.6
Taiwan Semiconductor Manufactrg Co Ltd - ADR 4.2
Berkshire Hathaway Inc Cl B 3.7
Meta Platforms Inc Cl A 3.4
Cash and Cash Equivalents 3.2
Booking Holdings Inc 2.9
Marsh & McLennan Cos Inc 2.5
Crh PLC 2.4
Ryanair Holdings PLC - ADR 2.3
Total allocation in top holdings 33.8
Portfolio characteristics
Standard deviation 10.52%
Dividend yield 1.67%
Yield to maturity -
Duration (years) -
Coupon -
Average credit rating Not rated
Average market cap (million) $825,830.1

Understanding returns

Annual compound returns (%)

1 MO 3 MO YTD 1 YR
{{snapShot.Return1Mth|customNumber:2}}{{snapShot.Return3Mth|customNumber:2}}{{snapShot.ReturnYTD|customNumber:2}}{{snapShot.Return1Yr|customNumber:2}}
3 YR 5 YR 10 YR INCEPTION
{{snapShot.Return3Yr|customNumber:2}}{{snapShot.Return5Yr|customNumber:2}}{{snapShot.Return10Yr|customNumber:2}}{{snapShot.ReturnInception|customNumber:2}}

Calendar year returns (%)

2024 2023 2022 2021
{{snapShot.Return1YrCalendar|customNumber:2}}{{snapShot.Return2YrCalendar|customNumber:2}}{{snapShot.Return3YrCalendar|customNumber:2}}{{snapShot.Return4YrCalendar|customNumber:2}}
2020 2019 2018 2017
{{snapShot.Return5YrCalendar|customNumber:2}}{{snapShot.Return6YrCalendar|customNumber:2}}{{snapShot.Return7YrCalendar|customNumber:2}}{{snapShot.Return8YrCalendar|customNumber:2}}

Range of returns over five years (November 1, 2009 - September 30, 2025)

Best return Best period end date Worst return
Worst period end date
16.61% May 2017 1.00% March 2020
Average return % of periods with positive returns Number of positive periods Number of negative periods
8.55% 100.00% 132 0

Q2 2025 Fund Commentary

Market commentary

Global equities declined early in the second quarter of 2025 because of U.S. tariff announcements. However, they later recovered as the U.S. administration paused tariffs. Over the entire quarter, global equities rose 5.7% in Canadian-dollar terms and 11.5% in U.S.-dollar terms.

The U.S. dollar weakened against most other major currencies. The U.S. passed a budget bill that was expected to significantly add to the national debt, which could lead to higher borrowing costs.

Performance

The Fund’s relative exposure to Oracle Corp., Microsoft Corp. and Taiwan Semiconductor Manufacturing Co. Ltd. had the most positive impact on performance. Relative exposure to UnitedHealth Group Inc., Berkshire Hathaway Inc. and Marsh & McLennan Cos. Inc. was negative for performance.

At the sector level, stock selection in information technology and industrials was positive for performance. Underweight exposure to information technology and overweight exposure to health care had a negative impact on performance.

Currency effects had a positive impact on performance.

Portfolio activity

The sub-advisor sold Johnson & Johnson, HF Sinclair Corp. and Edenred SE.

Outlook

The sub-advisor favours attractively valued global companies whose performance is not driven by macroeconomic events.

Setanta Asset Management Limited

Contact information

Toll free: 1-888-252-1847

{{ snapShot.FundName.replace("<em>", "").replace("</em>", "") }}
No matching records found.

Summary

For the period {{NAVPSPerformanceSummary.StartDate}} through {{NAVPSPerformanceSummary.EndDate}} with $10,000 CAD investment

Total returns performance

{{NAVPSPerformanceSummary.Growth | customPercentage}}

Last price

{{NAVPSPerformanceSummary.NAVPS | customCurrency}} CAD

as of market close {{NAVPSPerformanceSummary.NAVPSDate}}

Value of $10,000 investment

{{NAVPSPerformanceSummary.GrowthOfTenThousand | customCurrency}} CAD

Export to: